Olaparib for BRCAness Phenotype in Pancreatic Cancer: Phase II Study
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Olaparib (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 28 Sep 2017 Status changed from active, no longer recruiting to recruiting.
- 22 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Nov 2016 Planned primary completion date changed from 1 Dec 2019 to 1 Nov 2019.